Перевести на Переведено сервисом «Яндекс.Перевод»

Vanda Pharmaceuticals

Country
USA
Краткое название
Vanda Pharmaceuticals
Headquarters
2200 Pennsylvania Avenue NW Suite 300E
Members of the board

Mihael H. Polymeropoulos, M.D.,
President and Chief Executive Officer (Bio)
James Kelly, CFA,
Sr. Vice President, Chief Financial Officer & Treasurer (Bio)
Robert Repella,
Sr. Vice President, Chief Commercial Officer (Bio)
Gunther Birznieks,
Vice President, Business Development (Bio)
Deepak Phadke, Ph.D.,
Vice President of Manufa
Vice President, Program Director (Bio)
Marlene Dressman, Ph.D.,
Sr. Director, Program Director (Bio)
Louis Licamele, Ph.D.,
Head of Informatics (Bio)

Stage of the project
Production
Disease
Schizophrenia
Ticker
VNDA
Current owners

Howard Pien,
Director and Chairman of the Board (Bio)
Mihael H. Polymeropoulos, M.D.,
President and Chief Executive Officer (Bio)
Michael Cola,
Director (Bio)
Richard W. Dugan,
irector (Bio)
Steven Galson, M.D., M.P.H.,
Director (Bio)
Vincent J. Milano,
Director (Bio)
H. Thomas Watkins,
Director (Bio)

Assets
560.9300
Technology
Devices, Services, Technologies, Pharmaceuticals, Chemistry